Addex Therapeutics (ADXN) Interest Coverage Ratio: 2022-2025
Historic Interest Coverage Ratio for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to -125.75.
- Addex Therapeutics' Interest Coverage Ratio fell 112.08% to -125.75 in Q2 2025 from the same period last year, while for Jun 2025 it was 321.07, marking a year-over-year increase of 5014.69%. This contributed to the annual value of -776.78 for FY2024, which is 11021.98% down from last year.
- Latest data reveals that Addex Therapeutics reported Interest Coverage Ratio of -125.75 as of Q2 2025, which was down 497.22% from 31.66 recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Interest Coverage Ratio ranged from a high of 1,289.84 in Q1 2024 and a low of -125.75 during Q2 2025.
- Its 3-year average for Interest Coverage Ratio is 226.28, with a median of 16.01 in 2023.
- Within the past 5 years, the most significant YoY rise in Addex Therapeutics' Interest Coverage Ratio was 9,084.32% (2024), while the steepest drop was 1,560.79% (2024).
- Addex Therapeutics' Interest Coverage Ratio (Quarterly) stood at -48.05 in 2022, then skyrocketed by 96.71% to -1.58 in 2023, then plummeted by 1,560.79% to -26.29 in 2024, then plummeted by 112.08% to -125.75 in 2025.
- Its last three reported values are -125.75 in Q2 2025, 31.66 for Q1 2025, and -26.29 during Q4 2024.